Valuation Ligand Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX Other stock markets 10:59:52 2026-07-24 EDT			5-day change	1st Jan Change
297.62 ^USD	-1.50%		-1.88%	+57.45%

07-15	RBC Capital Adjusts Price Target on Ligand Pharmaceuticals to $340 From $262, Maintains Outperform Rating	MT
07-14	Ligand Pharmaceuticals Incorporated completed the acquisition of XOMA Royalty Corporation from a group of shareholders.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,581	1,128	1,245	2,025	3,721	5,986	-	-
Change	-	-56.28%	10.35%	62.59%	83.8%	60.87%	-	-
Enterprise Value (EV)	2,581	1,128	1,245	2,025	3,721	5,986	5,986	5,986
Change	-	-56.28%	10.35%	62.59%	83.8%	60.87%	0%	0%
P/E	46.2x	-33.7x	24.3x	-487x	30.8x	67.9x	35.5x	29.8x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	-0x	5x	-0x	-2.5x	0.4x	1.5x
Capitalization / Revenue	9.31x	5.75x	9.48x	12.1x	13.9x	20.7x	15.9x	13.9x
EV / Revenue	0x	0x	0x	0x	0x	20.7x	15.9x	13.9x
EV / EBITDA	0x	0x	0x	0x	0x	31.5x	21.4x	17x
EV / EBIT	0x	0x	0x	-0x	0x	41x	26.3x	22.2x
EV / FCF	0x	0x	0x	0x	0x	41.4x	28.2x	25.3x
FCF Yield	2.71%	10.6%	3.7%	4.7%	1.31%	2.42%	3.54%	3.95%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	3.34	-1.98	2.94	-0.22	6.13	4.449	8.5	10.16
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	277.1	196.2	131.3	167.1	268.1	289.8	375.4	431.4
EBITDA ¹	164.9	87.8	70.29	62.25	136.5	190	279.1	352.5
EBIT ¹	78.9	3.037	11.94	-22.61	41	146	227.3	269.5
Net income ¹	57.59	-33.36	52.15	-4.032	124.5	94.58	184.9	225.6
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	154.46	66.80	71.42	107.15	189.07	302.15	302.15	302.15
Nbr of stocks (in thousands)	16,712	16,894	17,436	18,895	19,682	19,812	-	-
Announcement Date	2/17/22	2/22/23	2/27/24	2/27/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
LIGAND PHARMACEUTICALS INCORPORATED	67.92x	-	-	-.--%	5.99B
ELI LILLY AND COMPANY	35.39x	12.58x	26.43x	0.57%	1,057B
JOHNSON & JOHNSON	27.79x	6.35x	17.58x	2.07%	624B
ABBVIE INC.	33.47x	7.59x	15.59x	2.68%	454B
ROCHE HOLDING AG	20.98x	4.63x	11.4x	2.86%	341B
NOVARTIS AG	21.62x	5.7x	13.97x	2.82%	297B
ASTRAZENECA PLC	21.08x	4.45x	12.3x	1.98%	262B
NOVO NORDISK A/S	14.13x	5.26x	10.83x	3.54%	215B
AMGEN INC.	24.37x	6.41x	11.32x	2.71%	201B
GILEAD SCIENCES, INC.	-47.14x	5.65x	31.2x	2.52%	162B
Average	21.96x	6.51x	16.74x	2.18%	361.99B
Weighted average by Cap.	24.79x	7.88x	18.52x	1.98%